Terms ending in 2033
Rapid Pathogen Screening, Inc.
Every in-force patent on Rapid Pathogen Screening, Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,413,587 | Histatin for Corneal Wound Healing and Ocular Surface Disease In force · Low confidence | Visus Therapeutics, Inc. | In force | Low confidence | |
| US 12,693,291 | METHODS AND DEVICES FOR DETECTING MxA IN A SAMPLE ON A SAMPLE ANAYSIS DEVICE In force · High confidence | Rapid Pathogen Screening, Inc. | In force | High confidence |
2 of 2 patents shown. Soonest term end first, then patent number.
1 of these is in force and held by Rapid Pathogen Screening, Inc..
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.